Moving Beyond Lifestyle Benefits Traditionally, employer-sponsored weight management programs, such as wellness support, gym reimbursement, and nutrition counseling, have been classified as "lifestyle benefits." However, as GLP-1 therapies gain FDA approval for cardiovascular, kidney, metabolic, and sleep-related conditions, treating them as lifestyle benefits ignores their role in preventing high-cost chronic disease and shifts avoidable risk back onto employers
For optimal safety, physicians should assess patients' psychiatric history and mental state before starting treatment
A pro-oxidative shift caused by GSH depletion triggers glutathionylation of CASP8 at residues Cys360 and Cys409 81
Are looking for a medically supervised, sustainable solution for long-term weight management
Cost and Accessibility Semaglutide, commonly sold under the brand names Ozempic and Wegovy, is a well-established medication
These medications have shown renoprotective effects in lupus models, suggesting potential as non-immunosuppressive agents to enhance renal function in autoimmune kidney diseases like LN (76)
